HealthShares Emerging Cancer
exchange-traded fund was higher for a second straight session.
, which surged 147% Friday after the Food and Drug Administration said the company's prostate cancer vaccine treatment, Provenge, was safe and effective in treating prostate cancer, was rising another 11.7%. The
was recently up 43 cents, or 1.8%, to $24.98.
Utility-related ETFs were also faring well. Among individual names,
Public Service Enterprise Group
were climbing 2.3% or more.
Utilities Select Sector SPDR
ETF was tacking on 2.2% to $40.59. The
ETF was higher by 1.9% to $143.47. The
iShares Dow Jones US Utilities
ETF was adding 1.6% to $98.67.
On the flip side, ETFs tracking homebuilders were the worst performers. Among homebuilder names,
was falling 3.5%,
was losing 3.3%,
was shedding 2.7% and
was down 1.9%.
ETF was sliding 1.3% at $32.14. The
iShares Dow Jones U.S. Home Construction
ETF was recently down 1.1% at $33.78.
SPDR S&P Semiconductor
ETF was also among Monday's losers as holding
Maxim Integrated Products
sank 2.4%. The ETF was sliding 59 cents, or 1.2%, to $48.23.